During the past decade, Stem cell and Regenerative Medicine institute (SCARM) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Stem cell and Regenerative Medicine institute (SCARM)" are "Heart Failure" (2 trials), "Nasolabial Folds" (1 trials) and "Skin Aging" (1 trials). Many other conditions were trialed in "Stem cell and Regenerative Medicine institute (SCARM)" in a lesser frequency.

Most popular intervention types in "Stem cell and Regenerative Medicine institute (SCARM)" are "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Fibroblast" (1 trials), "Intracoronary injection of stem cell" (1 trials) and "Intramyocardial injection of stem cell" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stem cell and Regenerative Medicine institute (SCARM)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Stem cell and Regenerative Medicine institute (SCARM)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Stem cell and Regenerative Medicine institute (SCARM), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stem cell and Regenerative Medicine institute (SCARM), 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".